The Asthma Allergy Foundation of America New England Chapter recently announced that allergist Xiu-Min Li, MD, from the Mt. Sinai Medical Center in New York, will be discussing her groundbreaking food allergy research in an informational session at Newton Wellesley Hospital in Massachusetts.
The presentation titled “Traditional Chinese Medicine and New Ideas for Allergy, Asthma and Eczema” will cover Dr. Li’s research and clinical experience as a pioneer in developing a botanical drug, based on Chinese herbal formulas, to treat asthma and allergic conditions.
Dr. Li has a unique combined expertise in allergy, immunology molecular biology and Chinese herbal medicine, and has become a leader in the scientific study of complementary and alternative medicine (CAM) for allergic disorders. She is director of the NIH/NCCAM funded Center of Excellence for Research in Complementary and Alternative Medicine (CERC), center for Chinese Herbal Therapy for Asthma, and sponsor of the US-FDA approved phase I and II clinical study of a botanical drug, ASHMI, for treating asthma. She is also the sponsor of a US-FDA approved clinical study of the Chinese herbal medicine FAHF-2 for food allergy. Her continued research may lead to the first generation of botanical drugs for asthma and food allergy.
October 19, 2010, 7pm
Newton Wellesley Hospital
Shipley Auditorium (2nd floor)
2014 Washington St. (Rt. 16), Newton MA